THE ALKYLATION OF DNA INVITRO BY 2,5-BIS(2-HYDROXYETHYLAMINO)-3,6-DIAZIRIDINYL-1,4-BENZOQUINONE (BZQ) .1.

被引：17

作者：

BUTLER, J

HOEY, BM

WARD, TH

机构：

来源：

关键词：

D O I：

10.1016/0006-2952(89)90281-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：923 / 927

页数：5

共 22 条

[1] RADIATION SENSITIZATION AND CHEMOPOTENTIATION - RSU-1069, A COMPOUND MORE EFFICIENT THAN MISONIDAZOLE INVITRO AND INVIVO
ADAMS, GE
AHMED, I
SHELDON, PW
STRATFORD, IJ
[J]. BRITISH JOURNAL OF CANCER, 1984, 49 (05) : 571 - 577
[2] Bender J F, 1983, Invest New Drugs, V1, P71
[3] BOSANQUET AG, 1985, INVEST NEW DRUG, V3, P43
[4] BUTLER J, 1987, British Journal of Cancer, V55, P53
[5] BUTLER J, 1988, BIOCHIM BIOPHYS ACTA, V925, P144
[6] POTENTIAL CENTRAL NERVOUS-SYSTEM ANTITUMOR AGENTS - AZIRIDINYLBENZOQUINONES .2.
CHOU, F
KHAN, AH
DRISCOLL, JS
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1976, 19 (11) : 1302 - 1308
[7] DERMER OC, 1969, ETHYLENIMINE OTHER A, P205
[8] DRIEBERGEN RJ, 1986, ANTICANCER RES, V6, P605
[9] DRISCOLL JS, 1974, CANCER CHEMOTH REP 3, V4, P1
[10] FURTHER INVESTIGATIONS OF ETHYLENIMINOQUINONES AND RELATED COMPOUNDS
GAUSS, W
PETERSEN, S
[J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 1957, 69 (08) : 252 - 257